SELECT TRIAL: Semaglutide, Central Fat, and Cardioprotection 🧪🏹🛡️
Dr RR Baliga's "Got Knowledge Doc" Podkast
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
🫀📉 Published in The Lancet (Oct 22, 2025): SELECT trial investigators report that semaglutide reduced MACE by 20% in patients with obesity but without diabetes—independent of weight loss. Waist circumference, not weight, tracked with outcomes, yet explained only 33% of the benefit. This landmark analysis redefines GLP-1RAs as disease-modifying agents, not just weight-loss drugs.
👉 Read here: https://doi.org/10.1016/S0140-6736(25)01375-3
#SELECTTrial #Semaglutide #Cardiovascular #Obesity #GLP1RA #TheLancet